Gene therapy investors
7 investors that name Gene therapy among their sectors are recorded here: 5 venture capital firms, 1 asset manager and 1 investor. Stated investment stages run from pre-seed to Series B. Most are headquartered in the United States (4), the United Kingdom (1) and the Netherlands (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Aescap Life Sciences biotech · life sciences · genetics · gene therapy |
Direct investor | Asset manager | Not applicable | Amsterdam, Netherlands |
| Atlas Venture biotechnology · life sciences · therapeutics · gene therapy |
Direct investor | Venture capital | Seed – Series A | Cambridge, United States |
| Civilization Ventures genomics · diagnostics · digital health · synthetic biology |
Direct investor | Venture capital | Pre-seed – Series A | United States |
| CureDuchenne Duchenne muscular dystrophy · biotech · gene therapy |
Direct investor | Other | Not stated | Newport Beach, United States |
| Medical Excellence Capital gene therapy · cell therapy · synthetic biology · regenerative medicine |
Direct investor | Venture capital | Seed – Series B | |
| SCI Ventures paralysis · spinal cord injury · biotech · neuroscience |
Direct investor | Venture capital | Seed – Series B | London, United Kingdom |
| Westlake Village BioPartners life sciences · biotech · therapeutics · gene therapy |
Direct investor | Venture capital | Not stated | Los Angeles, United States |